Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul;98(7):946-50.
doi: 10.1136/bjophthalmol-2013-304082. Epub 2014 Feb 13.

Macular abnormalities in Italian patients with retinitis pigmentosa

Affiliations
Free PMC article

Macular abnormalities in Italian patients with retinitis pigmentosa

Francesco Testa et al. Br J Ophthalmol. 2014 Jul.
Free PMC article

Abstract

Aim: To investigate the prevalence of macular abnormalities in a large Caucasian cohort of patients affected by retinitis pigmentosa (RP).

Methods: A retrospective study was performed by reviewing the medical records and optical coherence tomography (OCT) scans in a cohort of 581 RP patients in order to assess the presence of macular abnormalities -that is, cystoid macular oedema (CMO), epiretinal membrane (ERM), vitreo-macular traction syndrome, and macular hole.

Results: Macular abnormalities were observed in 524 (45.1%) out of the 1161 examined eyes. The most frequent abnormality was CMO, observed in 237 eyes (20.4%) from 133 patients (22.9%), followed by ERM, assessed in 181 eyes (15.6%) from 115 patients (19.8%). Moreover, vitreo-retinal abnormalities were significantly (p<0.05) associated with older age, cataract surgery, or cataract. CMO appeared to be significantly (p<0.05) associated with female gender, autosomic dominant inheritance pattern, and cataract.

Conclusions: Macular abnormalities are more frequent in RP compared to the general population. For that reason, screening RP patients with OCT is highly recommended to follow-up the patients, evaluate the natural history of disease, and identify those patients who could benefit from current or innovative therapeutic strategies.

Keywords: Diagnostic tests/Investigation; Dystrophy; Epidemiology; Macula; Retina.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of macular abnormalities in the study cohort of patients with retinitis pigmentosa.
Figure 2
Figure 2
Distribution of macular abnormalities in the study cohort of patients with retinitis pigmentosa stratified by (A) gender; (B) inheritance pattern; and (C) lens appearance. CMO, cystoid macular oedema; ERM, epiretinal membrane; FTMH, full thickness macular hole; LMH, lamellar macular hole; TMO, tractional macular oedema; VMT, vitreomacular traction syndrome.

References

    1. Hagiwara A, Yamamoto S, Ogata K, et al. Macular abnormalities in patients with retinitis pigmentosa: prevalence on OCT examination and outcomes of vitreoretinal surgery. Acta Ophthalmol 2011;89:122–5 - PubMed
    1. Fishman GA, Fishman M, Maggiano J. Macular lesions associated with retinitis pigmentosa. Arch Ophthalmol 1977;95:798–803 - PubMed
    1. Giusti C, Forte R, Vingolo EM. Clinical pathogenesis of macular holes in patients affected by retinitis pigmentosa. Eur Rev Med Pharmacol Sci 2002;6:45–8 - PubMed
    1. Testa F, Rossi S, Sodi A, et al. Correlation between photoreceptor layer integrity and visual function in patients with Stargardt disease: implications for gene therapy. Invest Ophthalmol Vis Sci 2012;53:4409–15 - PMC - PubMed
    1. Fishman GA. Retinitis pigmentosa. Genetic percentages. Arch Ophthalmol 1978;96:822–6 - PubMed

MeSH terms